NASDAQ:IOSP - Innospec Stock Price, Price Target & More

Innospec trades on the NASDAQ under the ticker symbol "IOSP."

Innospec announced a semiannual dividend on Wednesday, May 9th. Shareholders of record on Monday, May 21st will be given a dividend of $0.44 per share on Thursday, May 31st. This represents a yield of 1.18%. The ex-dividend date is Friday, May 18th. This is an increase from Innospec's previous semiannual dividend of $0.39. View Innospec's Dividend History.

Innospec Inc. (NASDAQ:IOSP) announced its quarterly earnings results on Tuesday, May, 8th. The specialty chemicals company reported $1.02 EPS for the quarter, beating the Zacks' consensus estimate of $0.91 by $0.11. The specialty chemicals company earned $360.70 million during the quarter, compared to analyst estimates of $308.90 million. Innospec had a return on equity of 14.91% and a net margin of 4.86%. The company's revenue was up 22.6% compared to the same quarter last year. During the same quarter last year, the firm posted $1.00 EPS. View Innospec's Earnings History.

Innospec is scheduled to release their next quarterly earnings announcement on Tuesday, August, 7th 2018. View Earnings Estimates for Innospec.

3 equities research analysts have issued 1 year target prices for Innospec's shares. Their forecasts range from $65.00 to $86.00. On average, they anticipate Innospec's share price to reach $75.50 in the next year. This suggests that the stock has a possible downside of 7.4%. View Analyst Ratings for Innospec.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Innospec in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Some companies that are related to Innospec include Huntsman (HUN), Ashland Global (ASH), W. R. Grace & Co (GRA), Olin (OLN), Univar (UNVR), Ingevity (NGVT), Balchem (BCPC), PQ Group (PQG), GCP Applied Technologies (GCP), KMG Chemicals (KMG), OCI Partners (OCIP), Innophos (IPHS), Nexeo Solutions (NXEO), Hawkins (HWKN) and Liquidmetal Technologies (LQMT).

Media coverage about IOSP stock has trended somewhat positive recently, Accern Sentiment reports. Accern identifies negative and positive press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Innospec earned a news sentiment score of 0.15 on Accern's scale. They also gave headlines about the specialty chemicals company an impact score of 47.71 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term.

Innospec's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Kirr Marbach & Co. LLC IN (0.75%), ZWJ Investment Counsel Inc. (0.25%), Creative Planning (0.06%), Municipal Employees Retirement System of Michigan (0.03%), Xact Kapitalforvaltning AB (0.02%) and Capital One National Association (0.02%). Company insiders that own Innospec stock include Brian Watt, Catherine Hessner, David Earl Williams, Hugh Aldous, Ian Cleminson, Ian Malcolm Mcrobbie, Joachim Roeser, Milton C Blackmore, Patrick Williams, Philip Curran and Philip John Boon. View Institutional Ownership Trends for Innospec.

IOSP stock was sold by a variety of institutional investors in the last quarter, including Kirr Marbach & Co. LLC IN, Municipal Employees Retirement System of Michigan and ZWJ Investment Counsel Inc.. Company insiders that have sold Innospec company stock in the last year include Brian Watt, Catherine Hessner, David Earl Williams, Hugh Aldous, Ian Cleminson, Ian Malcolm Mcrobbie, Milton C Blackmore, Patrick Williams, Philip Curran and Philip John Boon. View Insider Buying and Selling for Innospec.

IOSP stock was bought by a variety of institutional investors in the last quarter, including Creative Planning, Capital One National Association, First Citizens Bank & Trust Co. and Xact Kapitalforvaltning AB. View Insider Buying and Selling for Innospec.

Shares of IOSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of IOSP stock can currently be purchased for approximately $81.55.

Innospec has a market capitalization of $1.99 billion and generates $1.31 billion in revenue each year. The specialty chemicals company earns $61.80 million in net income (profit) each year or $4.66 on an earnings per share basis. Innospec employs 1,900 workers across the globe.

Innospec's mailing address is 8310 SOUTH VALLEY HIGHWAY SUITE 350, ENGLEWOOD CO, 80112. The specialty chemicals company can be reached via phone at 303-792-5554 or via email at [email protected]